You are in: eMedicine Specialties >
Pediatrics: General Medicine > Infectious Disease
Salmonella Infection
Article Last Updated: Jul 26, 2006
AUTHOR AND EDITOR INFORMATION
Section 1 of 10
Author: Archana Chatterjee, MD, PhD, Associate Professor of Pediatrics, Medical Microbiology and Immunology, and Pharmacy, Division of Pediatric Infectious Diseases, Chief of Division of Pediatric Infectious Diseases, Creighton University Medical Center; Hospital Epidemiologist and Medical Director of Infection Control, Children's Hospital
Archana Chatterjee is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, International Society for Infectious Diseases, Pediatric Infectious Diseases Society, and Society for Pediatric Research
Coauthor(s):
Meera Varman, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Infectious Diseases, Creighton University Medical Center;
Diana L Crevi, MD, Fellow in Pediatric Emergency Medicine, Department of Pediatrics, Schneider Children's Hospital of Long Island Jewish Medical Center
Editors: José Rafael Romero, MD, Director of Pediatric Infectious Diseases Fellowship Program, Associate Professor, Department of Pediatrics, Combined Division of Pediatric Infectious Diseases, Creighton University/University of Nebraska Medical Center; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus; Robert W Tolan Jr, MD, Chief of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine; Russell W Steele, MD, Professor and Vice Chairman, Department of Pediatrics, Head, Division of Infectious Diseases, Louisiana State University Health Sciences Center
Author and Editor Disclosure
Synonyms and related keywords:
Salmonella infection, bacterial gastroenteritis, infectious colitis, Salmonella typhi, S typhi, enteric fever, typhoid fever, Salmonella enteritidis, S enteritidis
Background
Salmonella, Shigella, Yersinia, and Campylobacter species and pathogenic Escherichia coli account for about 10-15% of the diarrheal illnesses of children presenting to the emergency department. In the United States, Salmonella is the most common cause of bacterial gastroenteritis. In most cases, Salmonella is a self-limiting disease causing mild gastroenteritis; however, it can lead to a wide spectrum of complications including bacteremia, severe local infections, enterocolitis, and enteric fever.
Pathophysiology
Salmonella organisms are gram-negative bacilli in the family Enterobacteriaceae. Differences in lipopolysaccharide (LPS) and flagellar structure generate the antigenic variation that is reflected in the more than 2,000 known serotypes. The principal reservoirs for nontyphoidal Salmonella organisms are poultry, livestock, reptiles, and pets. The mode of transmission is ingestion of foods of animal origin, including poultry, red meats, unpasteurized milk, and eggs that have been contaminated by infected animals or an infected human. Contact with infected reptiles, such as iguanas, pet turtles, and tortoises, and ingestion of contaminated water are other modes of transmission.
Salmonella typhi is the species known to cause enteric fever (typhoid fever). S typhi is found only in humans. In the United States, typhoid fever is usually caused by foreign travel to countries with contaminated food and drinking water or by ingestion of food contaminated by a chronic carrier.
Once ingested, Salmonella can gain access to the small intestine. If large enough numbers of bacteria are ingested, they can survive in the normally lethal acidic pH of the stomach. Salmonella enterica typhimurium interacts with the physiologic receptor for epidermal growth factor to co-opt the receptor's signal transduction mechanisms and penetrate the mucosal barrier.
Frequency
United States
More than 50,000 culture-confirmed cases of Salmonella gastroenteritis occur per year. Approximately 400 cases of typhoid fever are reported per year. More than two thirds of cases are acquired from foreign travel. From 1985-1994, travel to Mexico and India accounted for most cases of typhoid fever.
International
Typhoid fever is endemic in many developing areas of the world.
Mortality/Morbidity
Morbidity and mortality rates are highest in infants (most dangerous in infants <3 mo with bacteremia), elderly patients, and patients with sickle cell disease, AIDS, neoplasms, or other causes of immunocompromise.
Age
Attack rates are highest in persons younger than 5 years or older than 70 years.
History
Carefully obtain the patient's history to determine any potential sources of Salmonella and to help determine if the correct diagnosis has been made.
- General history
- Inquire about any recent travel abroad.
- Inquire about possible animal exposures, including contact with pet iguanas, turtles, tortoises, or other reptiles.
- Inquire whether any family members have current or recent gastroenteritis.
- Inquire whether any recent outbreaks have occurred in the community.
- Salmonella gastroenteritis
- The incubation period of Salmonella gastroenteritis is 6-72 hours.
- In most cases, children have cramping abdominal pain, nausea, vomiting, and loose watery stools.
- Stools may be bloody; however, this is not as common as in infection with Shigella.
- Fever, which rarely exceeds 39°C, occurs in approximately one half of infected patients.
- Symptoms usually resolve spontaneously in 2-7 days.
- Enteric fever (typhoid fever)
- Enteric fever is caused by S typhi and several other Salmonella serotypes.
- The incubation period for enteric fever is 3-60 days, but symptoms typically occur in 1-2 weeks.
- Patients may present with high fever, which rises in a steplike fashion.
- Other symptoms include anorexia, abdominal pain, malaise, myalgias, headache, cough, diarrhea or constipation, and delirium.
Physical
- Salmonella gastroenteritis
- On physical examination, patients may have signs of dehydration, such as delayed capillary refill, sunken eyes, dry mucous membranes, or tachycardia.
- Patients may have tenderness to palpation on abdominal examination, which sometimes can be difficult to differentiate from appendicitis.
- Rectal examination may reveal heme-positive stools, gross blood, or mucoid stools.
- Enteric fever (typhoid fever)
- A typical finding of enteric fever is relative bradycardia for the height of the fever.
- Hepatosplenomegaly may be found on examination.
- Patients with enteric fever may develop rose spots; these spots are blanching pink papules most commonly found on the anterior thorax. They usually fade about 3-4 days after appearance, are 2-4 mm in diameter, and occur in groups of 5-20.
Causes
- Numerous serotypes of Salmonella exist. Serogroups A through E are the main ones causing disease in humans. In the United States, serogroups B, C, and D are responsible for most infections.
- Salmonella enteritidis (serogroup D) is the most common cause of gastroenteritis.
- S typhi (serogroup D) and other serotypes are responsible for typhoid fever (enteric fever).
Colitis
Food Poisoning
Gastroenteritis
Shigella Infection
Other Problems to be Considered
Viral enteritis Toxic ingestions Gastroenteritis, Bacterial Parasitic infections
Lab Studies
- Complete blood cell count with differential
- CBC count is often 10,000-15,000 in simple gastroenteritis.
- Patients with enteric fever commonly have anemia, thrombocytopenia, or neutropenia, although a shift to more immature forms can be seen on the differential count.
- Cultures
- Isolation of Salmonella from cultures of stool, blood, urine, or bone marrow is diagnostic.
- Cultures of rose spots and/or bone marrow aspirate may be positive in enteric fever even when stool cultures are negative for Salmonella.
- Stool examination: Stool may be hemoccult positive and may be positive for fecal polymorphonuclear cells.
- Chemistry
- Electrolyte tests may reveal metabolic acidosis or other abnormalities consistent with dehydration.
- Patients with enteric fever may have mild hepatitis.
- Serologic tests: Tests for Salmonella agglutinins (febrile agglutinins, Widal test) may suggest infection with S typhi; however, they are not recommended because of the number of false-positive and false-negative results.
Imaging Studies
- Imaging studies are not necessary for most patients with simple gastroenteritis and enteric fever without any severe complications.
- Consider chest radiography if pneumonia is suggested as the result of bacteremia.
- Perform abdominal radiography if the patient presents with peritoneal signs on physical examination. Consider intestinal perforation as a complication of enteric fever.
- Perform a bone scan if osteomyelitis is considered as a complication of bacteremia. MRI, which is more sensitive, can be done to evaluate osteomyelitis.
Medical Care
- Salmonella gastroenteritis
- For uncomplicated gastroenteritis caused by nontyphoidal Salmonella species, antimicrobial therapy is not indicated because it does not shorten the duration of illness.
- Treatment involves monitoring hydration status and IV therapy to correct electrolyte imbalance or restore intravascular volume.
- Antidiarrheal agents may actually prolong GI transit time and the illness.
- Antimicrobial agents and hospital admission may be recommended in Salmonella gastroenteritis in infants younger than 3 months, infants younger than 12 months with temperatures higher than 39°C and unknown blood culture results, and patients with hemoglobinopathies, HIV infection or other causes of immunosuppression, neoplasms, or chronic GI illnesses.
- The recommended antibiotics for individuals at high risk of invasive disease include ampicillin, amoxicillin, trimethoprim-sulfamethoxazole (TMP-SMZ), cefotaxime, and ceftriaxone.
- Treatment of invasive Salmonella disease (bacteremia, extraintestinal manifestations)
- Antibiotic treatment includes ampicillin, amoxicillin, cefotaxime, ceftriaxone, chloramphenicol, TMP-SMZ, or a fluoroquinolone, if susceptible.
- A 14-day course of antibiotics is recommended for patients with bacteremia.
- Patients with localized infection, such as osteomyelitis or abscess, or patients with bacteremia and HIV infections should receive 4-6 weeks of therapy.
- For Salmonella meningitis, ceftriaxone or cefotaxime is recommended for 4 weeks or longer.
- Enteric fever caused by S typhi infection
- For S typhi infection, a 14-day course of chloramphenicol, ampicillin, or TMP-SMZ is indicated.
- In severe infection, parenteral therapy is indicated.
- Use antipyretics with caution or not at all because they may cause precipitous drops in temperature and shock.
- Relapse is common, and patients must be re-treated.
- Corticosteroids may be involved in treatment of patients with neurologic complications of enteric fever.
- In particular parts of the world, namely India, Pakistan, and Egypt, multiply antibiotic-resistant strains of S typhi are found. Travelers from these regions should be treated with a 7- to 10-day course of ceftriaxone or 5- to 7-day course of ciprofloxacin or ofloxacin.
- High-dose ampicillin or high-dose amoxicillin plus probenecid for 4-6 weeks has cured many chronic carriers.
Surgical Care
Cholecystectomy may be curative in carriers with chronic gallbladder disease.
Consultations
- Consider consultation with a pediatric infectious disease specialist if questions exist about the appropriate antibiotic for treatment or questions exist about the length of treatment of patients with documented Salmonella infection.
- Consider surgical consultation for patients with enteric fever who appear to have complications such as intestinal perforation, splenic rupture, or pancreatitis.
Diet
- Restrict initial oral intake to electrolyte solutions, such as Pedialyte or clear liquids.
- Add solid foods only when the diarrhea appears to be improving and dehydration is not present.
- Initially, children can be started on a BRAT diet (ie, bananas, rice, applesauce, toast) and then slowly advanced to a regular diet as tolerated.
In most simple gastroenteritis, antibiotics are not necessary and, in fact, can prolong the duration of illness.
Drug Category: Antibiotics
Patients who are susceptible to invasive disease, those with invasive Salmonella, and those with enteric fever require treatment with antimicrobials.
| Drug Name | Amoxicillin (Amoxil, Polymox, Trimox) |
| Description | Interferes with cell wall synthesis. High-dose amoxicillin can be used if treatment with parenteral therapy not necessary. |
| Adult Dose | 4-6 g/d PO divided tid |
| Pediatric Dose | 100 mg/kg/d PO divided q6h |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with allopurinol may increase risk of rash |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in patients with known renal failure |
| Drug Name | Ampicillin (Marcillin, Omnipen, Polycillin, Principen) |
| Description | Demonstrated effectiveness in treatment of gastroenteritis, invasive disease, and enteric fever. |
| Adult Dose | 500-3000 mg IV q4-6h; not to exceed 12 g/d |
| Pediatric Dose | 200-300 mg/kg/d IV divided q6h; not to exceed 12 g/d |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with allopurinol may increase risk of rash |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in renal failure; breastfeeding infants may have bowel flora modification, allergic response, and interference of culture results for fever workup |
| Drug Name | Ceftriaxone (Rocephin) |
| Description | Third-generation cephalosporin with broad gram-negative coverage and CNS penetration. Ceftriaxone or cefotaxime is considered DOC for Salmonella meningitis. |
| Adult Dose | 1-4 g/d IV/IM divided q12-24h |
| Pediatric Dose | Meningitis: 100 mg/kg/d IV divided q12-24h; not to exceed 4 g/24h Nonmeningitic dosage: 50-75 mg/kg/d IV divided q12-24h |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid may increase ceftriaxone levels; coadministration with ethacrynic acid, furosemide, or aminoglycosides may increase nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Caution with penicillin-allergic patients secondary to cross-reactivity with penicillins; caution with renal impairment; may cause reversible cholelithiasis, sludging in gallbladder, and jaundice; use with caution in neonates and continuous dosing because of risk of hyperbilirubinemia |
| Drug Name | Cefotaxime (Claforan) |
| Description | Third-generation cephalosporin. Cefotaxime or ceftriaxone considered DOC for treatment of Salmonella meningitis. |
| Adult Dose | 1-2 g/dose IV q6-8h |
| Pediatric Dose | Meningitis: 200 mg/kg/d IV divided q6h Nonmeningitic dosage: 100-200 mg/kg/d IV divided q6-8h |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid may increase cefotaxime levels; coadministration with furosemide or aminoglycosides may increase nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Caution with hypersensitivity to penicillin; adjust dosage in patients with renal impairment; may cause neutropenia, thrombocytopenia, eosinophilia, positive Coombs test, and elevated BUN, creatinine, and liver enzymes |
| Drug Name | Chloramphenicol (Chloromycetin) |
| Description | Considered by many to be DOC for treatment of enteric fever. PO chloramphenicol no longer available in United States. |
| Adult Dose | 50-100 mg/kg/d IV divided q6h; not to exceed 4 g/24h |
| Pediatric Dose | <2 weeks: 25 mg/kg/d IV divided q6h >2 weeks: 50-100 mg/kg/d IV divided q6h; not to exceed 4 g/24h |
| Contraindications | Documented hypersensitivity |
| Interactions | Concomitant use of phenobarbital and rifampin may lower serum levels; phenytoin may increase serum levels; may increase phenytoin levels, reduce metabolism of oral anticoagulants, and decrease absorption of vitamin B-12 |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | Caution in G-6-PD deficiency, renal and hepatic dysfunction, and neonates; monitoring of serum levels in neonates and infants is essential; may cause idiosyncratic marrow suppression known as gray baby syndrome |
| Drug Name | Trimethoprim-sulfamethoxazole (TMP-SMZ, Septra, Bactrim) |
| Description | Sulfonamide derivative. Inhibits bacterial growth by inhibiting synthesis of dihydrofolic acid. |
| Adult Dose | 160 mg/dose PO bid (based on TMP component) |
| Pediatric Dose | <2 months: Not recommended > 2 months: 8-10 mg/kg/d PO divided bid (based on TMP component) |
| Contraindications | Documented hypersensitivity |
| Interactions | May increase PT when used with warfarin (perform coagulation tests and adjust dose accordingly); coadministration with dapsone may increase blood levels of both drugs; coadministration of diuretics increases incidence of thrombocytopenia purpura in elderly patients; phenytoin levels may increase with coadministration; may potentiate effects of methotrexate in bone marrow depression; hypoglycemic response to sulfonylureas may increase with coadministration; may increase levels of zidovudine |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | May cause kernicterus in newborns; may cause blood dyscrasias, crystalluria, glossitis, renal or hepatic injury, GI irritation, or Stevens-Johnson syndrome; may cause hemolysis in patients with G-6-PD deficiency; should not be used at term in pregnancy; reduce dose in renal impairment |
| Drug Name | Ciprofloxacin (Cipro) |
| Description | Quinolone antibiotic considered DOC for adult chronic carriers with S typhi infection. |
| Adult Dose | 500 mg PO bid for 14 d |
| Pediatric Dose | 20-30 mg/kg/d PO divided q12h; must be used with caution in patients <18 y; benefits of treatment with drug must outweigh risks |
| Contraindications | Documented hypersensitivity |
| Interactions | Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations May increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT) |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | Has caused arthropathy in immature animals; adjust dose in patients with renal failure |
Drug Category: Glucocorticoids
Glucocorticoids have been demonstrated to have some benefit in patients with severe neurologic complications of enteric fever.
| Drug Name | Dexamethasone (Decadron) |
| Description | Demonstrated some potential benefits in patients with obtundation, shock, stupor, or coma from enteric fever. |
| Adult Dose | 3 mg/kg IV for 1 dose, followed by 1 mg/kg IV q6h for total duration of 48h |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | Barbiturates, carbamazepine, phenytoin, rifampin, and INH may reduce effects; estrogens may enhance effects |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | Adverse effects may include mood changes, seizures, hyperglycemia, diarrhea, GI bleeding, cushingoid effect, and cataracts with prolonged use; must taper drug and monitor for adrenal axis suppression |
Further Inpatient Care
- If admission is necessary, monitor the patient's hydration and electrolyte levels, continue IV or PO antibiotics as needed, and observe for and appropriately treat complications of Salmonella.
Further Outpatient Care
- Monitor patient's hydration status as an outpatient. Admission is warranted if the patient has signs and/or symptoms of dehydration.
- Monitor patients treated for enteric fever for possibility of relapse.
- Follow up on all blood cultures if the patient is being treated as an outpatient.
Deterrence/Prevention
- Good personal hygiene, hand washing, and appropriate sanitary practices deter spread of the disease.
- Standard precautions and contact precautions must be used during the entire hospitalization of patients, especially for children who are in diapers or are incontinent.
- For patients hospitalized with S typhi infection, precautions must be continued until results of 3 stool cultures are negative 48 hours after stopping antibiotic therapy.
- Typhoid vaccination can help deter typhoid fever.
- Although vaccinations enhance resistance to infection with S typhi, immunity is overcome by a large bacterial inoculum.
- Immunization is recommended for the following individuals: (1) those who travel to an endemic area, (2) those with intimate exposure to an individual known to be a carrier of typhoid fever, (3) laboratory workers with frequent contact with S typhi, and (4) individuals living in typhoid-endemic areas outside the United States.
- Three vaccinations are available in the United States.
- Oral Ty21a vaccine is a live attenuated vaccination that can be given to children aged 6 years or older.
- Vi capsular polysaccharide vaccine can be given to patients aged 2 years or older and consists of one intramuscular injection.
- Parenteral inactivated vaccine is indicated for children younger than 2 years and consists of 2 subcutaneous injections.
Complications
- Nontyphoidal salmonellosis
- Bacteremia
- Meningitis
- Pneumonia
- Endocarditis/pericarditis
- Osteomyelitis (most common in patients with sickle cell anemia)
- Hepatic/splenic abscess
- Typhoid fever (enteric fever)
- Intestinal perforation and severe hemorrhage (occurs in 1-10% of children)
- Toxic encephalopathy and cerebral thrombosis
- Hepatitis, pancreatitis, arthritis, and myocarditis
Prognosis
- Nontyphoidal salmonellosis
- Prognosis of patients with simple gastroenteritis is excellent except for very young infants or patients with debilitating diseases.
- The prognosis for Salmonella meningitis or endocarditis is poor.
- Typhoid fever (enteric fever)
- Therapy with antibiotics has decreased the mortality rate to 1%; however, prognosis depends on the extent of complications from the disease.
- Relapse is common after therapy for enteric fever.
- Chronic carrier state: Patients who continue to shed bacteria for more than 1 year (approximately 1% of patients) are considered chronic carriers.
Patient Education
- Good personal hygiene and hand washing are essential for all people involved in food handling.
- All medical personnel must also use standard precautions when treating patients with Salmonella to avoid patient-to-patient transmission.
- For excellent patient education resources, visit eMedicine's Public Health Center. Also, see eMedicine's patient education article Foreign Travel.
Medical/Legal Pitfalls
- Failure to consider S typhi as a differential diagnosis because the patient does not initially present with diarrhea and may have constipation
- Failure to ask about foreign travel and, therefore, not considering S typhi as a differential diagnosis
- Failure to aggressively treat infants younger than 3 months, patients with sickle cell disease, and patients who are immunocompromised and thus avoid potentially serious complications and poor outcome
Special Concerns
- Salmonella infections in day care
- When a child or a staff member in a daycare setting has been diagnosed with S typhi infection, stool specimens from all children and staff members of the daycare should be obtained. All infected individuals should be excluded from the center until results from 3 consecutive stool cultures are negative for children younger than 5 years. Children older than 5 years can return to group care, if diarrhea has resolved for 24 hours.
- When a child or adult contracts a case of Salmonella gastroenteritis (species other than S typhi), children or staff members should not be allowed to return to the day care center until they are asymptomatic. Asymptomatic individuals do not need to give stool specimens.
- Amieva MR. Important bacterial gastrointestinal pathogens in children: a pathogenesis perspective. Pediatr Clin North Am. 2005;52:749-77. [Medline].
- Behrman, RE, Kliegman, RM, Jenson, HB. Salmonella. In: Textbook of Pediatrics. 17th ed. 2003;912-919.
- Davis MA, Hancock DD, Besser TE. Multiresistant clones of Salmonella enterica: The importance of dissemination. J Lab Clin Med. 2002;140:135-41. [Medline].
- Fierer J, Guiney DG. Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J Clin Invest. 2001;107:775-80. [Medline].
- Fleisher, GR, Ludwig, SL, Henretig FM. Infectious Disease Emergencies. In: Textbook of Pediatric Emergency Medicine. 5th ed. Baltimore, Md:. 2005;783-851.
- Khan GQ, Kadri SM, Hassan G, et al. Salmonella typhi endocarditis: a case report. J Clin Pathol. 2003;56:801-2. [Medline]. [Full Text].
- Leonard MK, Murrow JR, Jurado R, Gaynes R. Salmonella meningitis in adults infected with HIV: case report and review of the literature. Am J Med Sci. 2002;323:266-8. [Medline].
- Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr. 2001;73:1124S-1130S. [Medline].
- Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med. Mar 23 1998;158(6):633-8. [Medline].
- Misra S, Diaz PS, Rowley AH. Characteristics of typhoid fever in children and adolescents in a major metropolitan area in the United States. Clin Infect Dis. May 1997;24(5):998-1000. [Medline].
- Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med. 2002;347:1770-82. [Medline].
- Pickering LK. Salmonella infections. Red Book 2003 Report of the Committee on Infectious Diseases, AAP. 2003;541-547. [Full Text].
- Rooney RM, Cramer EH, Mantha S, et al. A review of outbreaks of foodborne disease associated with passenger ships: evidence for risk management. Public Health Rep. 2004;119:427-34. [Medline].
- Rooney RM, Bartram JK, Cramer EH, et al. A review of outbreaks of waterborne disease associated with ships: evidence for risk management. Public Health Rep. 2004;119:435-42. [Medline].
- Torrey S, Fleisher G, Jaffe D. Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis. J Pediatr. May 1986;108(5 Pt 1):718-21. [Medline].
- Yates J. Traveler's diarrhea. Am Fam Physician. 2005;71:2095-100. [Medline].
Salmonella Infection excerpt Article Last Updated: Jul 26, 2006
|